Beta-glucans for Hospitalised Patients With COVID-19
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This randomised trial aims to assess the role of beta1-3 glucan supplementation in improving
clinical symptoms and other outcomes amongst hospitalised patients with COVID-19.